Skip to content
VC FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 14 SOURCES

Ysios Capital

Also known as Ysios Capital Partners, Ysios Capital Partners, SGEIC, S.A.

Life-sciences VC manager (SGEIC) founded 2008, offices in San Sebastián and Barcelona; invests in biotech companies developing novel therapeutics worldwide.

HEADQUARTERS
Barcelona, Spain
FOUNDED
2008
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
10 people

Focus

STAGES
Pre-SeedSeedSeries ASeries B
SECTORS
Biotech & Life SciencesHealthTech
ASSET MIX
Venture capitalDirect investments
GEOGRAPHY
Global

Overview

Ysios Capital is a venture capital firm specialised in life sciences, founded in 2008 with offices in San Sebastián and Barcelona; its management company, Ysios Capital Partners SGEIC, S.A., is registered with the CNMV. Its current main fund is Ysios BioFund III (vintage 2020, €216M); in March 2026 it launched InceptionBio, a €100M-target company-creation fund focused on Spain with CDTI (SICC Innvierte) in its first close. Ysios also acts as investment advisor to Telescope Biotech Fund, a listed-equities fund managed by Andbank Wealth Management.

Investment thesis

Invests globally in biotech ventures developing novel therapeutic drugs for indications with high unmet medical need, both asset-centric companies and product-enabling platforms; core focus on late preclinical and early clinical projects, investing in international syndicates.

PORTFOLIO (12)

  • Mineralys TherapeuticsNOTABLE
    Biotech & Life Sciences
  • Fusion PharmaceuticalsNOTABLE
    Biotech & Life Sciences · Acquired
  • Aura BiosciencesNOTABLE
    Biotech & Life Sciences · IPO
  • Memo TherapeuticsNOTABLE
    Biotech & Life Sciences · Acquired
  • Neurona Therapeutics
    Biotech & Life Sciences · Acquired
  • Minoryx Therapeutics
    Biotech & Life Sciences
  • Ona Therapeutics
    Biotech & Life Sciences
  • SpliceBio
    Biotech & Life Sciences
  • Anaconda Biomed
    HealthTech
  • Adcendo
    Biotech & Life Sciences
  • Xeltis
    HealthTech
  • Sanifit
    Biotech & Life Sciences · Acquired

People

  • Joël Jean-Mairet
    Managing Partner · source
  • Julia Salaverría
    Managing Partner · source
  • Karen Wagner
    Managing Partner · source
  • Joan Perelló
    Managing Partner · source
  • Cristina Garmendia
    General Partner · source
  • Jordi Xiol
    Partner · source
  • Guillem Laporta
    Partner · source
  • Arturo Urrios
    Partner · source
  • Iñigo López-Huerta
    CFO · source
  • Wen Wen Cheng
    General Counsel and Head of ESG · source

Links

Frequently asked questions

Ysios Capital is a VC fund based in Barcelona, Spain, founded in 2008.

Yes. Ysios Capital invests its own capital in private companies.

Ysios Capital invests at Pre-Seed, Seed, Series A and Series B stages in Biotech & Life Sciences and HealthTech.

Key people at Ysios Capital include Joël Jean-Mairet (Managing Partner), Julia Salaverría (Managing Partner), Karen Wagner (Managing Partner) and Joan Perelló (Managing Partner).

Ysios Capital's investments include Mineralys Therapeutics, Fusion Pharmaceuticals, Aura Biosciences, Memo Therapeutics, Neurona Therapeutics, Minoryx Therapeutics, Ona Therapeutics and SpliceBio, among others.

The most recent publicly reported investment by Ysios Capital is Anaconda Biomed ($56M financing (existing investor)), announced in Sep 2026.

Ysios Capital states that it accepts submissions through its official contact page.

Yes. Ysios Capital manages capital from outside investors.